La Food & Drug Administration (FDA) des \u00c9tats-Unis a approuv\u00e9 Byetta (ingr\u00e9dient actif ex\u00e9natide) pour le traitement du diab\u00e8te de type II en 2005. Administr\u00e9 par injection, des millions de personnes ont pris Byetta dans le but de r\u00e9duire leur glyc\u00e9mie. Malgr\u00e9 son approbation f\u00e9d\u00e9rale, Byetta s'est av\u00e9r\u00e9 \u00eatre un m\u00e9dicament \u00e0 la fois d\u00e9fectueux et dangereux. Un avocat peut vous aider \u00e0 d\u00e9poser une demande de dommages-int\u00e9r\u00eats si vous avez pris Byetta et subi un pr\u00e9judice en cons\u00e9quence.<\/p>\n
<\/p>\n
Napoli Shkolnik, PLLC is currently investigating cases for patients who have been diagnosed pancreatic cancer and thyroid cancer\u00a0while taking or after taking Byetta. These are potentially life-threatening conditions that may have a tremendous impact on a patient and his or her family, and we are prepared to seek financial compensation that can cover medical bills, lost income and the other losses and injuries associate with these side effects. Contact our offices today, or continue reading to learn more about this type 2 diabetes medication and the side effects it may cause.<\/p>\n
One of the most recent developments in Byetta side effects involves pancreatic cancer. According to a new study by researchers at the University of California, Los Angeles (UCLA), evidence of pre-cancerous cellular changes were found in diabetic patients taking incretin mimetics. The Food and Drug Administration (FDA) released a Drug Safety Communication regarding this new study in March of 2013, stating that the agency would evaluate the findings of this study. Incretin mimetics are a class of diabetic drugs, including Byetta, Januvia, Victoza and several others.<\/p>\n
<\/p>\n
Since it was approved by the U.S. Food and Drug Administration in 2005, millions of prescriptions for Byetta (exenatide) have been dispensed across the nation. From 2005 through 2009 alone, 7 million Byetta prescriptions were dispensed. Byetta is an injectable prescription medication for the treatment of type 2 diabetes, injected twice daily within 60 minutes before the first and last meals of the day. It stimulates the production of insulin in the pancreas and causes the stomach to empty itself more slowly. Combined with diet and exercise and possibly other diabetes medications, Byetta is meant to bring blood sugar to a more optimum level.<\/p>\n
Byetta is not a cure for type 2 diabetes, a condition that has been diagnosed in millions of Americans. It is instead meant to control this type of diabetes by stimulating insulin production. It is estimated that many more Americans are at risk of developing type 2 diabetes or are unaware that they are in the early stages of the condition.<\/p>\n
With the number of patients currently suffering from type 2 diabetes, it is no wonder that so many Byetta prescriptions have been written and filled. Unfortunately, as the drug increased in popularity it became evident that patients were suffering from serious side effects.<\/p>\n
<\/p>\n
Byetta a \u00e9t\u00e9 associ\u00e9e \u00e0 un certain nombre de probl\u00e8mes de sant\u00e9 graves, dont certains peuvent \u00eatre mortels s'ils ne sont pas trait\u00e9s. Ceux-ci inclus:<\/p>\n
En fait, entre les ann\u00e9es 2005 et 2008, la FDA a re\u00e7u 78 rapports de patients ayant d\u00e9velopp\u00e9 des probl\u00e8mes r\u00e9naux<\/a> en cons\u00e9quence directe de la prise de Byetta. Parmi ceux-ci, 18 ont n\u00e9cessit\u00e9 une dialyse, deux ont n\u00e9cessit\u00e9 une greffe de rein et quatre sont d\u00e9c\u00e9d\u00e9s.<\/p>\n <\/p>\n Si vous pensez que vous avez \u00e9t\u00e9 l\u00e9s\u00e9 en cons\u00e9quence directe de la prise de Byetta, vous pouvez avoir une cause d'action contre le fabricant de Byetta - Amylin Pharmaceuticals - ou une autre partie le long de la cha\u00eene de fabrication ou de distribution. Afin d'obtenir des dommages-int\u00e9r\u00eats dans le cadre d'une action civile, vous devrez prouver la n\u00e9gligence du fabricant du m\u00e9dicament et que le m\u00e9dicament d\u00e9fectueux vous a caus\u00e9 un pr\u00e9judice. Des exemples de n\u00e9gligence peuvent inclure\u00a0:<\/p>\n Vous devrez \u00e9galement prouver que vos dommages n'auraient pas \u00e9t\u00e9 encourus sans la prise de Byetta.<\/p>\n <\/p>\n Although Byetta is still approved for the treatment of type 2 diabetes in adults, it is possible that patients may experience serious and life-changing side effects. Some may even be at risk of losing their lives from these. Those who have suffered injury of this kind may be entitled to financial compensation for pain, suffering, medical care and lost earnings. Future medical expenses and loss of future earnings may also be covered, depending on the case.<\/p>\n Since 2000 alone, the attorneys at Napoli Shkolnik, PLLC have recovered in excess of $2 billion in settlements and awards. We are fully committed to representing the interests of the injured, helping them seek justice in the wake of the physical pain, emotional trauma and financial losses they have experienced. We go up against the most formidable opponents, negotiating fair settlements and fighting for favorable verdicts in order to help our clients begin rebuilding and moving on with their lives. We are ready to see how we can help with your Byetta lawsuit and welcome you to prendre contact<\/a> un avocat contentieux pharmaceutique<\/a> at our law office to discuss your rights and options. Your initial consultation is free.<\/p>\n Depending upon the state in which you live, the statute of limitations for filing a defective drug claim is usually between two and four years from the date of discovery of illness. To ensure that you file a claim within the time limits, make sure you contact the attorneys at Napoli Shkolnik, PLLC as soon as possible. We are ready to meet with you today!<\/p>","protected":false},"excerpt":{"rendered":" The U.S. Food & Drug Administration (FDA) approved Byetta (active ingredient exenatide) for the treatment of type II diabetes in 2005. Given via injection, millions of individuals have taken Byetta…<\/p>","protected":false},"featured_media":0,"menu_order":59,"template":"","practiceareas_category":[743],"class_list":["post-5670","practiceareas","type-practiceareas","status-publish","hentry","practiceareas_category-pharmaceutical-litigation"],"acf":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/practiceareas\/5670","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/practiceareas"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/types\/practiceareas"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/practiceareas\/5670\/revisions"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/media?parent=5670"}],"wp:term":[{"taxonomy":"practiceareas_category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/practiceareas_category?post=5670"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Ai-je une cause d'action contre le fabricant de Byetta\u00a0?<\/h3>\n
\n
Engagez une action en justice maintenant pour r\u00e9cup\u00e9rer les dommages<\/h3>\n